A Phase 2 interventional study of NSP and chitosan nanoparticles gel loaded by quercetin and NSP and chitosan nanoparticles gel in Periodontal Pocket, sponsored by Mansoura University. Active, not recruiting at 1 site in Egypt. Open to participants aged 25 Years to 55 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-05-21.
Sponsored by Mansoura University · Phase 2, Interventional, and Treatment
the proposed study aims to investigate the effect of Quercetin in treatment of periodontitis patients
the proposed study aims to investigate the effect of Quercetin in treatment of periodontitis patients not having systemic diseases.the 2ry aim of study to estimate the neacular factor kabba B level in gingival crevicular fluids.
1,635 studies on the registry are indexed under Periodontitis; 327 are open to participants now.
This study's planned enrollment of 60 is above the median of 45 across 1,191 interventional studies indexed under Periodontitis.
Browse Periodontitis studies →Mansoura University is the lead sponsor of 1,077 studies on the registry; 183 are open to participants now.
Of its 9 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
selected patients receive SRP and chitosan nanoparticles gel loaded by quercetin
Drug: NSP and chitosan nanoparticles gel loaded by quercetin
selected patients receive SRP and chitosan nanoparticles gel
Drug: NSP and chitosan nanoparticles gel
NSPT
Procedure: scaling and root planning
healthy individual act as control group
NSP and chitosan nanoparticles gel loaded by quercetin
NSP and chitosan nanoparticles gel
NSPT
assessment clinical attachment level by UNC 15 periodontal probe
Time frame: 12 weeks
assessment of the gingival crevicular levels of NF-κB by Elisa kit
Time frame: 12 weeks
Plan to share: Undecided — Clinical effect of Quercetin in treatment of periodiontal pocket
No publications or documents are linked to this record.
This study is active, not recruiting, as verified in May 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Mansoura University